Pulmatrix, Inc. current report, 24 June 2015

Abrir documento

Pulmatrix, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Pulmatrix, Inc. on June 30, 2015, covering events occurring on June 24, 2015. The filing primarily addresses the appointment of a new Chief Financial Officer and updates to Board committee assignments following a recent merger transaction.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation and corporate governance changes.

Material Changes

  • Executive Appointment: William Duke, Jr. was appointed Chief Financial Officer (CFO), Principal Financial Officer, and Principal Accounting Officer effective June 24, 2015.
  • Compensation Package:
    • Annual Base Salary: $300,000.
    • Sign-on Bonus: $30,000.
    • Annual Discretionary Bonus: Up to 35% of base salary.
    • Equity Grant: 235,224 stock options at an exercise price of $11.00 per share (closing price on grant date). The options vest over four years (25% on the first anniversary, remaining 75% monthly).
  • Severance Provisions:
    • Termination without cause/Good reason: 9 months base salary, 75% pro rata bonus, 9 months COBRA, and acceleration of equity vesting for the 9-month period.
    • Termination within 12 months of Change in Control: 12 months base salary, pro rata target bonus, 12 months COBRA, and full acceleration of unvested equity.
  • Board Committee Assignments: Following the merger closing on June 15, 2015, the Board appointed new members to the Audit, Compensation, and Nominating and Governance committees.

Guidance, Outlook, and Risks

The filing contains no financial guidance, outlook, or discussion of operational risks. The primary contingency noted is that severance benefits are subject to the execution of a release of claims and compliance with restrictive covenants.

Investor Verification Checklist

  • Verify the vesting schedule and exercise price of the 235,224 stock options granted to the new CFO.
  • Confirm the specific terms of the "Change in Control" definition within the employment agreement to understand full severance triggers.
  • Review the press release (Exhibit 99.1) for additional context on the merger transaction mentioned in the Board committee section.
  • Check subsequent filings for the impact of the new CFO on financial reporting timelines or internal controls.